» Articles » PMID: 37223043

Baseline Level and Change Trajectory of the Triglyceride-glucose Index in Relation to the Development of NAFLD: a Large Population-based Cohort Study

Overview
Specialty Endocrinology
Date 2023 May 24
PMID 37223043
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Insulin resistance (IR) and nonalcoholic fatty liver disease (NAFLD) are closely related. The triglyceride-glucose index (TyG index) has been proposed as a new indicator of IR. It remains unclear whether the triglyceride-glucose (TyG) index is prospectively associated with incident nonalcoholic fatty liver disease (NAFLD).

Methods: This large-scale study comprised 1 prospective cohort totaling 22,758 subjects without NAFLD at baseline who underwent repeated health examinations and 1 subcohort totaling 7,722 subjects with more than three visits. The TyG index was ascertained mathematically by ln (fasting triglycerides [mg/dL] × fasting glucose [mg/dL]/2). NAFLD was diagnosed by ultrasound without other concomitant liver diseases. A combinatorial Cox proportional hazard model and latent class growth mixture modeling method were used to identify the association of the TyG index and its transition trajectories with NAFLD risk.

Results: During 53,481 person-years of follow-up, there were 5319 incident cases with NAFLD. Compared with those in the lowest quartile of the baseline TyG index, participants in the highest quartile had 2.52-fold (95% confidence interval, 2.21-2.86) higher odds of incident NAFLD. Similarly, restricted cubic spline analysis showed a dose-response relationship ( nonlinearity<0.001). Subgroup analyses showed a more significant association in the female and normal body size populations ( for interaction<0.001). Three distinct trajectories of changes in the TyG index were identified. Compared with the continued low group, the moderately increasing and highly increasing groups conferred 1.91-fold (1.65-2.21) and 2.19-fold (1.73-2.77) higher NAFLD risk, respectively.

Conclusions: Participants with a higher baseline TyG index or a higher excessive TyG exposure were associated with an increased NAFLD risk. The findings imply that lifestyle interventions and modulation of IR might be considered to both reduce TyG index levels and prevent NAFLD development.

Citing Articles

Predictive Value of the Triglyceride-Glucose Index for Metabolic-Associated Fatty Liver Disease in Individuals with Different Metabolic Obese Phenotypes.

Lv D, Wang Z, Liu H, Meng C Diabetes Metab Syndr Obes. 2025; 18():125-133.

PMID: 39834613 PMC: 11742748. DOI: 10.2147/DMSO.S500042.


Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.

Zhang F, Han Y, Wu Y, Bao Z, Zheng G, Liu J Ann Med. 2024; 56(1):2409342.

PMID: 39348274 PMC: 11443541. DOI: 10.1080/07853890.2024.2409342.


Association between triglycerideglucose index and arterial stiffness progression A retrospective cohort study.

Zhu X, Chen J, Liu X, Wang Y Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(6):951-960.

PMID: 39311791 PMC: 11420968. DOI: 10.11817/j.issn.1672-7347.2024.230592.


Triglyceride glucose index as a predictor for non-alcoholic fatty liver disease: insights from a longitudinal analysis in non-obese individuals.

Ning Q, Zheng K, Yan J, Zhu C Front Med (Lausanne). 2024; 11:1429413.

PMID: 39040897 PMC: 11260781. DOI: 10.3389/fmed.2024.1429413.


Relationship of triglyceride-glucose index to gallstone prevalence and age at first gallstone surgery in American adults.

Wang J, Li H, Hu J, Shi R, Qin C, Chen X Sci Rep. 2024; 14(1):16749.

PMID: 39033195 PMC: 11271289. DOI: 10.1038/s41598-024-67883-0.


References
1.
James P, Oparil S, Carter B, Cushman W, Dennison-Himmelfarb C, Handler J . 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2013; 311(5):507-20. DOI: 10.1001/jama.2013.284427. View

2.
Zheng R, Du Z, Wang M, Mao Y, Mao W . A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. Lipids Health Dis. 2018; 17(1):262. PMC: 6247753. DOI: 10.1186/s12944-018-0913-3. View

3.
Teo B, Zhang L, Guh J, Tang S, Jha V, Kang D . Glomerular Filtration Rates in Asians. Adv Chronic Kidney Dis. 2018; 25(1):41-48. DOI: 10.1053/j.ackd.2017.10.005. View

4.
Kitae A, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M . The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Can J Gastroenterol Hepatol. 2019; 2019:5121574. PMC: 6800935. DOI: 10.1155/2019/5121574. View

5.
Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J . The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017; 16(1):15. PMC: 5248473. DOI: 10.1186/s12944-017-0409-6. View